These guys are definitely at or near their bottom. Legal issues re: option grants are behind them and cost was all written down last quarter. They are facing pressure from Medicare cuts and changes, but they are going through some gradual restructuring to cut costs and adapt. This company has become more than a little bloated via various acquisitions over the years, and earnings pressure has finally forced them to reevaluate their organization and cut fat. Plenty of money to be made here in the long term, but could be a little flat until we start to see a rise towards historical highs.
$27.65 (07/30/08)
